Menu Search
Equities

Beijing Luzhu Biotechnology Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
2480:HKG.HZ

Beijing Luzhu Biotechnology Co Ltd

Actions
  • Price (HKD)25.98
  • Today's Change3.10 / 13.55%
  • Shares traded18.80k
  • 1 Year change+18.63%
  • Beta--
Data delayed at least 15 minutes, as of Feb 16 2026 04:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Beijing Luzhu Biotechnology Co Ltd is a China-based company primarily engaged in the research, development and production of vaccines and therapeutic biologics. The Company is also engaged in the development of innovative human vaccines and therapeutic biologics to prevent and control infectious diseases and treat cancer and autoimmune diseases. The Company's products include clinical-stage product candidates and pre-clinical-stage product candidates. The core product LZ901 is mainly used to prevent shingles caused by the varicella-zoster virus in adults aged 50 years and above. The Company mainly conducts its businesses in the domestic market.

  • Revenue in HKD (TTM)0.00
  • Net income in HKD-153.70m
  • Incorporated2001
  • Employees197.00
  • Location
    Beijing Luzhu Biotechnology Co LtdNo. 3 Guangtong StreetIndustrial Development Zone, Tongzhou DBEIJING ChinaCHN
  • Websitehttp://www.luzhubiotech.com
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.